November 28th 2024- Dr. Annalisa Ruggeri- Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

CME Congresses .

November 28th 2024- Dr. Annalisa Ruggeri- Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

CME Congresses .

November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

November 11th 2024- Prof. Mohamed Kharfan-Dabaja- How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm

CME Congresses .

November 11th 2024- Prof. Mohamed Kharfan-Dabaja- How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm

October 30th 2024- Prof. Shai Izraeli- Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms

CME Congresses .

October 30th 2024- Prof. Shai Izraeli- Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms

October 23rd 2024- Prof. Per Ljungman- Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients for Use in Clinical Trials

CME Congresses .

October 23rd 2024- Prof. Per Ljungman- Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients for Use in Clinical Trials

October 13th 2024- Prof. Carlo Visco- More is Not Always Better

CME Congresses .

October 13th 2024- Prof. Carlo Visco- More is Not Always Better

October 6th 2024- Dr. Natalia Zing- The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T-and NK-cell lymphomas

CME Congresses .

October 6th 2024- Dr. Natalia Zing- The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T-and NK-cell lymphomas

September 30th 2024- Prof. Yves Chalandon- Nilotinib with or without Cytarabine for Philadelphia-positive Acute Lymphoblastic Leukemia

CME Congresses .

September 30th 2024- Prof. Yves Chalandon- Nilotinib with or without Cytarabine for Philadelphia-positive Acute Lymphoblastic Leukemia

September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy

CME Congresses .

September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy

September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis

CME Congresses .

September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis